Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Sandson, N. B. Articles by Phillips, B. Search for Related Content PubMed Citation Articles by Sandson, N. B. Articles by Phillips, B. Schizophrenia Spectrum Disorders Miscellaneous Somatic Therapies Other Somatic Therapy Other Neuroleptics

Clozapine Case Series

Clozapine is not a drug that is ever used casually. Patients generally are afflicted with severe illnesses and have demonstrated treatment resistance and/or intolerance to other therapeutic options before clozapine is seriously considered. When the clinical stakes are this high, it is especially important that physicians gain an appreciation for the various drug–drug interactions that can significantly increase or decrease clozapine blood levels; such pharmacokinetic changes can derail clozapine treatment by producing clozapine toxicity or loss of antipsychotic efficacy, respectively. The authors present a case series of five drug–drug interactions involving clozapine, each of which illustrates different mechanisms by which the metabolism of clozapine can be altered. Exploring these cases should help clinicians anticipate and avoid these undesirable drug–drug interactions.

This article has been cited by other articles:

				K. Brownlowe and C. Sola Clozapine Toxicity in Smoking Cessation and With Ciprofloxacin * Case Report Psychosomatics, April 1, 2008; 49(2): 176 - 176. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us